Log in
Enquire now
Aprogen

Aprogen

Antibodies, biosimilars, generics

OverviewStructured DataIssuesContributors

Contents

aprogen.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biosimilar
Biosimilar
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Engineering
Engineering
Location
Seongnam
Seongnam
Investors
‌
Lindeman Asia Global Pioneer
DA Value Investment
DA Value Investment
Total Funding Amount (USD)
16,412,606
Latest Funding Round Date
May 1, 2019
Latest Funding Type
‌
Venture round
Patents Assigned (Count)
2
Country
South Korea
South Korea

Other attributes

Postmoney Valuation
1,040,000,000
Latest Funding Round Amount (USD)
16,412,606
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Aprogen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.